Dissent In Parliament As Commission Claims EU Pharma Revision Will Improve Competitiveness and Access

Proposals on regulatory data protection and transferable exclusivity vouchers to encourage antimicrobial R&D have received mixed reactions from the parliament’s rapporteurs for the draft legislation.

Pill capsule with the EU flag. Healthcare in the European Union concept
The EU pharma revision process has begun at the European Parliament • Source: Shutterstock

Plans for the overhaul of the EU pharmaceutical legislation have begun what will likely be a long and tortuous legislative journey after Florian Schmidt of the European Commission formally presented the proposals to the European Parliament’s environment and public health committee (ENVI) on 20 September.

The presentation covered all the key points of the revision, including plans to “modulate” regulatory data protection on medicines. However,...

More from Europe

More from Geography